Effects of Korean red ginseng supplementation on muscle glucose uptake in high-fat fed rats

Chinese Journal of Natural Medicines

Volumn 11, Issue 5, 2013, Pages 494-499

  Jung, Hyun Lyung ^a   Kang, Ho Youl ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Insulin resistance; Korean red ginseng; Muscle glucose uptake; Plasma lipids

Indexed keywords

CHOLESTEROL; FATTY ACID; GINSENG EXTRACT; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EPITORCHEALIS MUSCLE; FATTY ACID BLOOD LEVEL; GINSENG; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; MALE; MUSCLE LEVEL; MUSCLE METABOLISM; NONHUMAN; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

INSULIN RESISTANCE; KOREAN RED GINSENG; MUSCLE GLUCOSE UPTAKE; PLASMA LIPIDS;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MUSCLE, SKELETAL; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; RATS; TRIGLYCERIDES;

EID: 84890816908     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(13)60090-4     Document Type: Article

References (42)

1. Chung SH, Choi CG, Park SH Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice [J]. Arch Pharm Res 2001, 24(3):214-218.
2. Sotaniemi EA, Haapakoski E, Rautio A Ginseng therapy in non-insulin-dependent diabetic patients [J]. Diabetes Care 1995, 18(10):1373-1375.
3. Inoue M, Wu CZ, Dou DQ, et al. Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals [J]. Phytomedicine 1999, 6(4):257-265.
4. Lee HJ, Lee YH, Park SK, et al. Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats [J]. Metabolism 2009, 58(8):1170-1177.
5. Vuksan V, Sievenpiper JL Herbal remedies in the management of diabetes: lessons learned from the study of ginseng [J]. Nutr Metab Cardiovasc Dis 2005, 15(3):149-160.
6. Yeh GY, Eisenberg DM, Kaptchuk TJ, et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes [J]. Diabetes Care 2003, 26(4):1277-1294.
7. Kimura M, Waki I, Tanaka O, et al. Pharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix [J]. J Pharmacobiodyn 1981, 4(6):402-409.
8. Yokozawa T, Kobayashi T, Oura H, et al. Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats [J]. Chem Pharm Bull 1985, 33(2):869-872.
9. Sievenpiper JL, Arnason JT, Leiter LA, et al. Variable effects of American ginseng: a batch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affect postprandial glycemia[J]. Eur J Clin Nutr 2003, 57(2):243-248.
10. Vuksan V, Sievenpiper JL, Wong J, et al. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals [J]. Am J Clin Nutr 2001, 73(4):753-758.
11. Vuksan V, Stavro MP, Sievenpiper JL, et al. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes [J]. Diabetes Care 2000, 23(9):1221-1226.
12. Ohtsubo K, Chen MZ, Olefsky JM, et al. Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport [J]. Nat Med 2011, 17(9):1067-1075.
13. Kahn SE Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes [J]. J Clin Endocrinol Metab 2001, 86(9):4047-4058.
14. Liu TP, Liu IM, Cheng JT Improvement of insulin resistance by panax ginseng in fructose-rich chow-fed rats [J]. Horm Metab Res 2005, 37(3):146-151.
15. Su CF, Cheng JT, Liu IM Increase of acetylcholine release by Panax ginseng root enhances insulin secretion in Wistar rats [J]. Neurosci Lett 2007, 412(2):101-104.
16. Noma A, Okabe H, Kita M Determination of serum cholinesterase activity by means of automatic titration [J]. Rinsho Byori 1973, 21(5):457-460.
17. Cacho J, Sevillano J, de Castro J, et al. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats [J]. Am J Physiol Endocrinol Metab 2008, 295(5):E1269-E1276.
18. Fisher JS, Nolte LA, Kawanaka K, et al. Glucose transport rate and glycogen synthase activity both limit skeletal muscle glycogen accumulation [J]. Am J Physiol Endocrinol Metab 2002, 282(6):E1214-E1221.
19. Sherman WM, Katz AL, Cutler CL, et al. Glucose transport: locus of muscle insulin resistance in obese Zucker rats [J]. Am J Physiol 1988, 255(3 Pt 1):E374-E382.
20. Jung HL, Kwak HE, Kim SS, et al. Effects of Panax ginseng supplementation on muscle damage and inflammation after uphill treadmill running in humans [J]. Am J Chin Med 2011, 39(3):441-450.
21. Shin SK, Kwon JH, Jeong YJ, et al. Supplementation of cheonggukjang and red ginseng cheonggukjang can improve plasma lipid profile and fasting blood glucose concentration in subjects with impaired fasting glucose [J]. J Med Food 2011, 14(1-2):108-113.
22. Attele AS, Zhou YP, Xie JT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component [J]. Diabetes 2002, 51(6):1851-1858.
23. Lim S, Yoon JW, Choi SH, et al. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model [J]. Metabolism 2009, 58(1):8-15.
24. Xie JT, Zhou YP, Dey L, et al. Ginseng berry reduces blood glucose and body weight in db/db mice [J]. Phytomedicine 2002, 9(3):254-258.
25. Kumar S, Khanna SS Insulin administration in the frog Rana tigrina: studies on the blood glucose and the histology of the endocrine pancreas [J]. Gegenbaurs Morphol Jahrb 1978, 124(6):893-894.
26. DeFronzo RA, Bonadonna RC, Ferrannini E Pathogenesis of NIDDM. A balanced overview [J]. Diabetes Care 1992, 15(3):318-368.
27. Perseghin G, Bonfanti R, Magni S, et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease [J]. Am J Physiol Endocrinol Metab 2006, 291(4):E697-E703.
28. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents [J]. Diabetes 1999, 48(8):1600-1606.
29. DeFronzo RA, Jacot E, Jequier E, et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization [J]. Diabetes 1981, 30(12):1000-1007.
30. Henriksen EJ, Bourey RE, Rodnick KJ, et al. Glucose transporter protein content and glucose transport capacity in rat skeletal muscles [J]. Am J Physiol 1990, 259(4 Pt 1):E593-E598.
31. Kim HY, Kim K. Regulation of signaling molecules associated with insulin action, insulin secretion and pancreatic beta-cell mass in the hypoglycemic effects of Korean red ginseng in Goto-Kakizaki rats [J]. J Ethnopharmacol, 142(1): 53-58.
32. Kim JH, Hahm DH, Yang DC, et al. Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat [J]. J Pharmacol Sci 2005, 97(1):124-131.
33. Chien KL, Hsu HC, Su TC, et al. Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese [J]. J Lipid Res 2007, 48(11):2499-2505.
34. Hadaegh F, Khalili D, Ghasemi A, et al. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men [J]. Nutr Metab Cardiovasc Dis 2009, 19(6):401-408.
35. Tziomalos K, Kakafika AI, Athyros VG, et al. The role of statins for the primary and secondary prevention of coronary heart disease in women [J]. Curr Pharm Des 2009, 15(10):1054-1062.
36. Hwang SY, Son DJ, Kim IW, et al. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits [J]. Phytother Res 2008, 22(6):778-783.
37. Erdman JW Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA [J]. Circulation 2000, 102(20):2555-2559.
38. Shin DH, Heo HJ, Lee YJ, et al. Amaranth squalene reduces serum and liver lipid levels in rats fed a cholesterol diet [J]. Br J Biomed Sci 2004, 61(1):11-14.
39. Potter SM Overview of proposed mechanisms for the hypocholesterolemic effect of soy [J]. J Nutr 1995, 125(S3):606-611.
40. Oakenfull D Soy protein, saponins and plasma cholesterol [J]. J Nutr 2001, 131(11):2971-2972.
41. Delarue J, Magnan C Free fatty acids and insulin resistance [J]. Curr Opin Clin Nutr Metab Care 2007, 10(2):142-148.
42. Kim SP, Catalano KJ, Hsu IR, et al. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia [J]. Am J Physiol Endocrinol Metab 2007, 292(6):E1590-E1598.